Drug recall D-0283-2024
Product
Rifampin Capsules USP 150mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured Lupin Limited, Aurangabad 431 210 INDIA, NDC 68180-658-06
Reason for recall
Subpotent Drug and Failed Impurities/Degradation Specifications
Lots and codes
A200816 exp 1/2024 A201248 exp 3/2024
Recall details
- Recalling firm
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Quantity
- 15,576 Bottles
- Distribution
- Product was distributed to 32 Wholesale/distributor accounts who further distributed the product to 156 distribution sites.
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 5, 2024
- Terminated
- August 27, 2024
Related products
- Rifampin – drug information
- NDC 68180-658 Rifampin · Rifampin 150 mg/1 · Lupin Pharmaceuticals, Inc.
- NDC 68180-659 Rifampin · Rifampin 300 mg/1 · Lupin Pharmaceuticals, Inc.